跳至主要内容
临床试验/NCT01960634
NCT01960634已完成不适用

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

Grupo Español Multidisciplinar de Melanoma13 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
58
试验地点
13
主要终点
Rate of patient in which BRAF V600 in blood samples is present/absent

研究概览

简要总结

This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples.

Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice.

The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of melanoma and BRAFV600
  • Signed Informed Consent Form
  • Unresectable phase III or phase IV melanoma
  • The patients should be starting a treatment for melanoma (either first line or subsequent lines)

排除标准

  • 未提供

结局指标

主要结局

Rate of patient in which BRAF V600 in blood samples is present/absent

时间窗: two years

次要结局

  • Rate of patients with BRAFV600 present in tumor sample vs blood sample(two years)

研究者

发起方
Grupo Español Multidisciplinar de Melanoma
申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验